These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CAPITOL ACQUISITION CORP. II
|
||
|
(Exact Name of Registrant as Specified in Its Charter)
|
||
|
Delaware
|
27-4749725
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
Large accelerated filer
|
o
|
Accelerated filer
|
o
|
|
Non-accelerated filer
|
x
|
Smaller reporting company
|
o
|
|
(Do not check if smaller reporting company)
|
|
Page
|
|
|
Part I. Financial Information
|
|
|
Item 1. Financial Statements
|
|
|
Condensed Balance Sheets
|
3
|
|
Condensed Statement of Operations
|
4
|
|
Condensed Statement of Changes in Stockholders’ Equity
|
5-6
|
|
Condensed Statement of Cash Flows
|
7-8
|
|
Notes to Unaudited Condensed Financial Statements
|
9-15
|
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
16-17
|
|
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk
|
17
|
|
Item 4. Controls and Procedures
|
17-18
|
|
Part II. Other Information
|
|
|
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
|
18-19
|
|
Item 6. Exhibits
|
19
|
|
Signatures
|
20
|
|
September 30,
2013
|
December 31,
2012
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets
|
||||||||
|
Cash
|
$ | 542,190 | $ | 2,577 | ||||
|
Cash and cash equivalents held in trust account, interest income
available for working capital and taxes
|
23,070 | - | ||||||
|
Accrued interest receivable
|
2,000 | - | ||||||
|
Prepaid expenses and other current assets
|
79,625 | - | ||||||
|
Due from affiliate
|
5,216 | - | ||||||
|
Total current assets
|
652,101 | 2,577 | ||||||
|
Cash and cash equivalents held in trust account, restricted
|
200,000,000 | - | ||||||
|
Other assets
|
13,400 | - | ||||||
|
Deferred offering costs
|
- | 165,198 | ||||||
|
Total assets
|
$ | 200,665,501 | $ | 167,775 | ||||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 185,477 | $ | 20 | ||||
|
Deferred rent
|
1,340 | - | ||||||
|
Note payable to related party
|
- | 150,000 | ||||||
|
Total current liabilities
|
186,817 | 150,020 | ||||||
|
Commitments and contingencies
|
||||||||
|
Common stock, subject to possible redemption, 18,798,215 shares at redemption value
|
187,982,148 | - | ||||||
|
Stockholders’ equity
|
||||||||
|
Preferred stock, $0.0001 per share, 1,000,000 shares authorized, none issued or outstanding
|
- | - | ||||||
|
Common stock, $0.0001 par value, 200,000,000 shares authorized; 25,000,000 shares issued and outstanding at September 30, 2013; 5,175,000 shares issued and outstanding at December 31, 2012(1)(2)
|
620 | 517 | ||||||
|
Additional paid-in capital
|
12,975,932 | 24,483 | ||||||
|
Deficit accumulated during development stage
|
(480,016 | ) | (7,245 | ) | ||||
|
Total stockholders’ equity
|
12,496,536 | 17,755 | ||||||
|
Total liabilities and stockholders’ equity
|
$ | 200,665,501 | $ | 167,775 | ||||
|
(1)
|
Share amounts have been retroactively restated to reflect the contribution to the Company of 105,184 shares by the Company’s Sponsor on March 25, 2013 and a stock dividend of 0.2 shares for each outstanding share of common stock on May 9, 2013 (see Note 7)
|
|
(2)
|
Share amounts include 1,125,000 shares that are subject to forfeiture if the last sales prices of the Company’s stock does not equal or exceed $13.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period within four years following the closing of the Company’s initial business combination. The number of shares at December 31, 2012 includes an aggregate of 675,000 shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. The over-allotment option was partially exercised by the underwriters.
|
|
For the
three months ended September 30, 2013
|
For
the
three months ended September 30, 2012
|
For the
nine months ended September 30, 2013
|
For the
nine months ended September 30, 2012
|
For the period from August 9, 2010
(inception)
through
September 30, 2013
|
||||||||||||||||
|
Revenue
|
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
|
Formation and operating costs
|
291,762 | 1,701 | 497,841 | 2,269 | 505,086 | |||||||||||||||
|
Loss from operations
|
(291,762 | ) | (1,701 | ) | (497,841 | ) | (2,269 | ) | (505,086 | ) | ||||||||||
|
Interest income
|
19,017 | - | 25,070 | - | 25,070 | |||||||||||||||
|
Net loss
|
$ | (272,745 | ) | $ | (1,701 | ) | $ | (472,771 | ) | $ | (2,269 | ) | $ | (480,016 | ) | |||||
|
Weighted average number of common shares outstanding, basic and diluted
(1)(2)
|
6,201,785 | 5,175,000 | 5,697,795 | 5,175,000 | ||||||||||||||||
|
Basic and diluted net loss per share
|
$ | (0.04 | ) | $ | - | $ | (0.08 | ) | $ | - | ||||||||||
|
(1)
|
Share amounts have been retroactively restated to reflect the contribution to the Company of 105,184 shares by the Company’s Sponsor on March 25, 2013 and a stock dividend of 0.2 shares for each outstanding share of common stock on May 9, 2013 (see Note 7)
|
|
(2)
|
Share amounts include 1,125,000 shares that are subject to forfeiture if the last sales prices of the Company’s stock does not equal or exceed $13.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period within four years following the closing of the Company’s initial business combination. The number of shares at December 31, 2012 includes an aggregate of 675,000 shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. The over-allotment option was partially exercised by the underwriters.
|
|
Common Stock
|
Deficit | |||||||||||||||||||
|
Shares
|
Amount
|
Additional
paid –in capital
|
accumulated during
development stage
|
Total
stockholders’ equity
|
||||||||||||||||
|
Balance, August 9, 2010 (inception)
|
- | $ | - | $ | - | $ | - | $ | - | |||||||||||
|
Common stock issued at approximately $0.006 per share to initial stockholders on February 3, 2011
(1) (2)
|
5,175,000 | 517 | 24,483 | - | 25,000 | |||||||||||||||
|
Net loss for the year ended December 31, 2011
|
- | - | - | (2,477 | ) | (2,477 | ) | |||||||||||||
|
Balance, December 31, 2011
|
5,175,000 | 517 | 24,483 | (2,477 | ) | 22,523 | ||||||||||||||
|
Net loss for the year ended December 31, 2012
|
- | - | - | (4,768 | ) | (4,768 | ) | |||||||||||||
|
Balance, December 31, 2012
|
5,175,000 | 517 | 24,483 | (7,245 | ) | 17,755 | ||||||||||||||
|
Sale of 20,000,000 units, net of underwriters’ discount and offering expenses (includes 18,798,215 shares subject to possible conversion) on May 15, 2013
|
20,000,000 | 2,000 | 195,331,700 | - | 195,333,700 | |||||||||||||||
|
Common Stock
|
Deficit
|
|||||||||||||||||||
|
Shares
|
Amount
|
Additional
paid –in capital
|
accumulated during
development stage
|
Total
stockholders’ equity
|
||||||||||||||||
|
Forfeiture of initial stockholders’ shares pursuant to partial exercise of underwriters’ over-allotment
|
(175,000 | ) | (17 | ) | 17 | - | - | |||||||||||||
|
Proceeds subject to possible conversion of 18,798,215 shares
|
- | (1,880 | ) | (187,980,268 | ) | - | (187,982,148 | ) | ||||||||||||
|
Proceeds from issuance of sponsors’ warrants, at $1 per warrant
|
- | - | 5,600,000 | - | 5,600,000 | |||||||||||||||
|
Net loss for the nine months ended September 30, 2013 (Unaudited)
|
- | - | - | (472,771 | ) | (472,771 | ) | |||||||||||||
|
Balance, September 30, 2013 (Unaudited)
|
25,000,000 | $ | 620 | $ | 12,975,932 | $ | (480,016 | ) | $ | 12,496,536 | ||||||||||
|
(1)
|
Share amounts have been retroactively restated to reflect the contribution to the Company of 105,184 shares by the Company’s Sponsor on March 25, 2013 and a stock dividend of 0.2 shares for each outstanding share of common stock on May 9, 2013 (see Note 7)
|
| (2) | Share amounts include 1,125,000 shares that are subject to forfeiture if the last sales prices of the Company’s stock does not equal or exceed $13.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period within four years following the closing of the Company’s initial business combination. The number of shares at December 31, 2012 includes an aggregate of 675,000 shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters. The over-allotment option was partially exercised by the underwriters. |
|
For the
nine months ended September 30, 2013
|
For the
nine months ended September 30, 2012
|
For the
period from
August 9, 2010
(inception) through September 30, 2013
|
||||||||||
|
Cash Flows from Operating Activities
|
||||||||||||
|
Net loss
|
$ | (472,771 | ) | $ | (2,269 | ) | $ | (480,016 | ) | |||
|
Adjustments to reconcile net loss to net cash used in operating activities
|
||||||||||||
|
Deferred rent
|
1,340 | - | 1,340 | |||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Other current assets
|
- | 1,256 | - | |||||||||
|
Prepaid expenses
|
(79,625 | ) | - | (79,625 | ) | |||||||
|
Accrued interest receivable
|
(2,000 | ) | - | (2,000 | ) | |||||||
|
Other asset
|
(13,400 | ) | - | (13,400 | ) | |||||||
|
Accounts payable and accrued expenses
|
144,457 | (856 | ) | 144,477 | ||||||||
|
Net cash used in operating activities
|
(421,999 | ) | (1,869 | ) | (429,224 | ) | ||||||
|
Cash Flows from Investing Activities
|
||||||||||||
|
Trust Account, restricted
|
(200,000,000 | ) | - | (200,000,000 | ) | |||||||
|
Trust Account, interest income
available for working capital
and taxes
|
(23,070 | ) | - | (23,070 | ) | |||||||
|
Net cash used in investing activities
|
(200,023,070 | ) | - | (200,023,070 | ) | |||||||
|
Cash Flows from Financing Activities
|
||||||||||||
|
Gross proceeds from initial public offering
|
200,000,000 | - | 200,000,000 | |||||||||
|
Due from affiliate
|
(41 | ) | - | (41 | ) | |||||||
|
Proceeds from related party
|
- | - | 219,729 | |||||||||
|
Repayment of due to related party
|
- | - | (219,729 | ) | ||||||||
|
Proceeds from notes payable, related party
|
- | - | 150,000 | |||||||||
|
Repayment of notes payable, related party
|
(150,000 | ) | - | (150,000 | ) | |||||||
|
Proceeds from issuance of stock to initial stockholders
|
- | - | 25,000 | |||||||||
|
Proceeds from issuance of sponsors’ warrants
|
5,600,000 | - | 5,600,000 | |||||||||
|
Payment of underwriting discount and offering expenses
|
(4,465,277 | ) | - | (4,630,475 | ) | |||||||
|
Net cash provided by financing activities
|
200,984,682 | - | 200,994,484 | |||||||||
|
Capitol Acquisition Corp. II
(a development stage company)
Condensed Statement of Cash Flows (Continued)
(unaudited)
|
||||||||||||
|
For the
nine months ended September 30, 2013
|
For the
nine months ended September 30, 2012
|
For the
period from
August 9, 2010
(inception) through September 30, 2013
|
||||||||||
|
Net increase (decrease) in cash
|
539,613 | (1,869 | ) | 542,190 | ||||||||
|
Cash at beginning of period
|
2,577 | 33,589 | - | |||||||||
|
Cash at end of period
|
$ | 542,190 | $ | 31,720 | $ | 542,190 | ||||||
|
Supplemental Disclosure of Non-cash Investing and Financing Activities:
|
||||||||||||
|
Accrual for offering costs charged to additional paid in capital
|
$ | 35,825 | $ | 17,589 | $ | 35,825 | ||||||
|
Exhibit No.
|
Description
|
|
|
31.1
|
Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2
|
Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32
|
Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
CAPITOL ACQUISITION CORP. II
|
||
|
By:
|
/s/ Mark D. Ein
|
|
|
Mark D. Ein
|
||
|
Chief Executive Officer
(Principal executive officer)
|
||
|
By:
|
/s/ L. Dyson Dryden
|
|
|
L. Dyson Dryden
|
||
|
Chief Financial Officer
(Principal financial and accounting officer)
|
||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|